Publications by authors named "Alain Berrier"
Article Synopsis
- The study evaluated the effectiveness and safety of combining lapatinib with concurrent chemoradiotherapy (CRT) for patients with advanced head and neck cancer.
- A total of 67 patients were enrolled; results showed a complete response rate of 53% with lapatinib compared to 36% with a placebo at six months post-treatment.
- The combination treatment led to better progression-free survival and overall survival rates, particularly in cases of p16-negative disease.
